BM-A1 Clinical Trial
Our nutritional products are supported by extensive in vitro and in vivo data obtained from animals and humans. This approach to scientific validation ensures that appropriate indications are identified for our products and that product label claims can be supported. The Company's current portfolio of nutritional products includes BM-A1, BM-A2, and BM-A3.
Our pipeline is supported by ongoing product research and development which is focused on anti-aging interventions using the calorie restriction animal model to discovery innovative CR mimetics. Our nutritional product development follows the highest scientific standards for validation using both animal models and human clinical testing.
Learn more about our Research and Development Approach.